penicillin-g rs powder for solution for injection
reyoung pharmaceutical co. ltd. - benzylpenicillin (benzylpenicillin sodium) - powder for solution for injection - 1000000iu
sertraline hydrochloride tablet, film coated
viwit pharmaceutical co., ltd. - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - sertraline hydrochloride tablets are indicated for the treatment of the following [see clinical studies (14)] : - major depressive disorder (mdd) - obsessive-compulsive disorder (ocd) - panic disorder (pd) - posttraumatic stress disorder (ptsd) - social anxiety disorder (sad) - premenstrual dysphoric disorder (pmdd) sertraline hydrochloride tablets are contraindicated in patients: - taking, or within 14 days of stopping, maois, (including the maois linezolid and intravenous methylene blue) because of an increased risk of serotonin syndrome [see warnings and precautions (5.2), drug interactions (7.1)] . - taking pimozide [see drug interactions (7.1)] . - with known hypersensitivity to sertraline (e.g., anaphylaxis, angioedema) [see adverse reactions (6.1, 6.2)]. risk summary overall, available pub
co-amoxisaph 375 375mg film-coated tablet
sapphire lifesciences pvt. ltd.; importer: ollen pharma trading, inc.; distributor: ollen pharma trading, inc. - co-amoxiclav - film-coated tablet - 375mg
co-amoxisaph 457 457 mg/5 ml powder for oral suspension
aaron healthcare and export pvt. ltd.; importer: nelpa lifesciences, inc.; distributor: nelpa lifesciences, inc. - co-amoxiclav - powder for oral suspension - 457 mg/5 ml
isosorbide mononitrate tablet, extended release
shandong new time pharmaceutical co., ltd. - isosorbide mononitrate (unii: lx1oh63030) (isosorbide mononitrate - unii:lx1oh63030) - isosorbide mononitrate extended-release tablets are indicated for the prevention of angina pectoris due to coronary artery disease. the onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode. isosorbide mononitrate extended-release tablets are contraindicated in patients who have shown hypersensitivity or idiosyncratic reactions to other nitrates or nitrites.
milrinone lactate injection, solution
shandong new time pharmaceutical co., ltd. - milrinone lactate (unii: 9k8xr81mo8) (milrinone - unii:ju9yax04c7) - milrinone lactate injection is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure. patients receiving milrinone lactate should be observed closely with appropriate electrocardiographic equipment. the facility for immediate treatment of potential cardiac events, which may include life threatening ventricular arrhythmias, must be available. the majority of experience with intravenous milrinone lactate has been in patients receiving digoxin and diuretics. milrinone lactate injection is contraindicated in patients who are hypersensitive to it.
celecoxib capsule
yabao pharmaceutical co., ltd. beijing - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib capsules are indicated for the management of the signs and symptoms of oa [ see clinical studies (14.1) ] for the management of the signs and symptoms of ra [ see clinical studies (14.2) ] for the management of the signs and symptoms of jra in patients 2 years and older [ see clinical studies (14.3) ] for the management of the signs and symptoms of as [ see clinical studies (14.4) ] for the management of acute pain in adults [ see clinical studies (14.5) ] for the management of primary dysmenorrhea [ see clinical studies (14.5) ] celecoxib capsules are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to celecoxib, any components of the drug product [see warnings and precautions (5.7, 5.
ceftriaxone for injection powder for solution for i/m and i/v injection
reyoung pharmaceutical co. ltd - ceftriaxone (ceftriaxone sodium) - powder for solution for i/m and i/v injection - 1000mg
co-amoxisaph 375 375mg film-coated tablet
sapphire lifesciences pvt. ltd.; importer: ollen pharma trading inc.; distributor: ollen pharma trading inc. - co-amoxiclav - film-coated tablet - 375mg
fad ophthalmic solution 0.05%"santen" (fad点眼液0.05%「サンテン」)
santen pharmaceutical co.,ltd. - flavin adenine dinucleotide sodium - yellow to orange-yellow, limpid, ophthalmic solution, 5ml, (bottle) clear and colorless, (cap) vivid yellow green